Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea
· Delayed Price · Currency is KRW 11,470
+70 (0.61%)
At close: Apr 28, 2026
Bio Solution Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 273.36 | -11,928 | -1,800 | -697.54 |
| Depreciation & Amortization | 2,177 | 1,908 | 1,800 | 1,536 |
| Loss (Gain) From Sale of Assets | 1.2 | -53.69 | - | - |
| Asset Writedown & Restructuring Costs | 8.44 | - | - | - |
| Loss (Gain) From Sale of Investments | - | - | -103.52 | -347.5 |
| Loss (Gain) on Equity Investments | -4,448 | 7,112 | - | - |
| Stock-Based Compensation | 248.48 | 42.15 | 29.77 | - |
| Provision & Write-off of Bad Debts | -14.2 | -21.6 | -6.99 | -41.85 |
| Other Operating Activities | 1,159 | 2,448 | 404.27 | 206.46 |
| Change in Accounts Receivable | -181.11 | -578.12 | 696.67 | -633.85 |
| Change in Inventory | 244.96 | -74.13 | -907.88 | 151.05 |
| Change in Accounts Payable | -203.01 | 180.53 | 96.44 | -127.37 |
| Change in Other Net Operating Assets | -577.43 | -1,321 | -1,896 | -2,652 |
| Operating Cash Flow | -1,312 | -2,286 | -1,686 | -2,606 |
| Capital Expenditures | -184.98 | -379.79 | -1,391 | -2,179 |
| Sale of Property, Plant & Equipment | 189.23 | 172.48 | - | - |
| Sale (Purchase) of Intangibles | -546.53 | -230.29 | -1,114 | -298.84 |
| Investment in Securities | 1,217 | 24,693 | 6,262 | 3,453 |
| Other Investing Activities | 62.18 | 137.59 | -0.18 | -179.02 |
| Investing Cash Flow | 953.52 | 24,302 | 3,756 | 795.88 |
| Long-Term Debt Repaid | -926.93 | -14,851 | -792.65 | -667.56 |
| Net Debt Issued (Repaid) | -926.93 | -14,851 | -792.65 | -667.56 |
| Issuance of Common Stock | 339.99 | - | 508.5 | 1,211 |
| Other Financing Activities | -61.42 | 100 | 112.14 | -1.2 |
| Financing Cash Flow | -648.36 | -14,751 | -172.02 | 541.74 |
| Foreign Exchange Rate Adjustments | -32.38 | 171.48 | -15.13 | 4.03 |
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - |
| Net Cash Flow | -1,039 | 7,436 | 1,883 | -1,264 |
| Free Cash Flow | -1,497 | -2,666 | -3,077 | -4,785 |
| Free Cash Flow Margin | -9.85% | -20.69% | -39.73% | -53.87% |
| Free Cash Flow Per Share | -60.22 | -110.86 | -128.79 | -202.87 |
| Cash Interest Paid | 118.37 | 126.42 | 37.51 | 50.16 |
| Cash Income Tax Paid | -188 | -290.2 | 120.85 | 112.78 |
| Levered Free Cash Flow | -3,003 | - | -3,942 | - |
| Unlevered Free Cash Flow | -1,244 | - | -3,917 | - |
| Change in Working Capital | -716.6 | -1,793 | -2,011 | -3,262 |
Source: S&P Capital IQ. Standard template. Financial Sources.